Search alternatives:
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
ae decrease » we decrease (Expand Search), _ decrease (Expand Search), a decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i ae » i a (Expand Search), i e (Expand Search), i de (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
ae decrease » we decrease (Expand Search), _ decrease (Expand Search), a decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i ae » i a (Expand Search), i e (Expand Search), i de (Expand Search)
-
101
-
102
Depletion of SNEV decreases the splicing efficiency of nuclear extracts
Published 2011“…Lane 1 shows the unspliced adenoviral pre-mRNA. A decrease of the second catalytical step of the reaction was observed in the SNEV depleted extracts when compared to depleted controls, where irrelevant antibodies were used for depletion (lanes 3 and 4) or where untreated NE was used for splicing (lane 2). …”
-
103
-
104
Solicited local AEs.
Published 2022“…Percentages reflect <i>n</i>/<i>N</i> where <i>n</i> is the number of participants with one or more AEs and <i>N</i> is the number of participants with available reactogenicity data after the given dose (solicited AEs) or the number of participants who received the given dose (unsolicited AEs). …”
-
105
-
106
-
107
-
108
-
109
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…</p>Results<p>In a dose-dependent manner, ruxolitinib addition synergizes with UCB-Tregs to suppress SLE-PBMC proliferation, inhibit CD8<sup>+</sup> T cells, and reduce phosphorylation of STAT3/STAT5/AKT in CD8<sup>+</sup> T cells. …”
-
110
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…</p>Results<p>In a dose-dependent manner, ruxolitinib addition synergizes with UCB-Tregs to suppress SLE-PBMC proliferation, inhibit CD8<sup>+</sup> T cells, and reduce phosphorylation of STAT3/STAT5/AKT in CD8<sup>+</sup> T cells. …”
-
111
Triple stain for miR-200b, AE1/AE3, and laminin-5γ2 at the invasive front.
Published 2017“…<b>(B-F)</b> Enlarged area from A. <b>(B)</b> Tumor budding cells co-expressing cytokeratin AE1/AE3 and laminin-5γ2 (red) appear yellow as indicated by white arrowheads. …”
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120